Back to mobile site

Barclays Reiterates Equalweight Rating on CME Group (CME)

June 3, 2025 8:55 AM EDT Send to a Friend
Barclays analyst Benjamin Budish reiterated an Equalweight rating and $283.00 price target on CME Group (NASDAQ: CME).The analyst comments "Combined ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login